| SC 13G | 2022-02-14 | Avidity Partners Management LP | Phathom Pharmaceuticals, Inc. | 1,896,000 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-10 | Invesco Ltd. | Phathom Pharmaceuticals, Inc. | 2,067,356 | 6.6% | EDGAR |
| SC 13G/A | 2022-02-10 | Yamada Tadataka | Phathom Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-10 | JANUS HENDERSON GROUP PLC | Phathom Pharmaceuticals, Inc. | 1,841,357 | 5.9% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | Phathom Pharmaceuticals, Inc. | 1,927,844 | 6.1% | EDGAR |
| SC 13D/A | 2021-11-12 | TAKEDA PHARMACEUTICAL CO LTD | Phathom Pharmaceuticals, Inc. | 7,459,304 | 19.2% | EDGAR |
| SC 13D/A | 2021-04-06 | TAKEDA PHARMACEUTICAL CO LTD | Phathom Pharmaceuticals, Inc. | 8,672,000 | 22.3% | EDGAR |
| SC 13D/A | 2021-04-01 | TAKEDA PHARMACEUTICAL CO LTD | Phathom Pharmaceuticals, Inc. | 8,672,000 | 22.3% | EDGAR |
| SC 13G/A | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | Phathom Pharmaceuticals, Inc. | 3,825,008 | 12.3% | EDGAR |
| SC 13G/A | 2021-02-12 | Invesco Ltd. | Phathom Pharmaceuticals, Inc. | 2,054,438 | 6.6% | EDGAR |
| SC 13G/A | 2021-02-11 | Yamada Tadataka | Phathom Pharmaceuticals, Inc. | 1,687,721 | 5.4% | EDGAR |
| SC 13G/A | 2021-02-11 | Socks David A | Phathom Pharmaceuticals, Inc. | 1,505,945 | 4.8% | EDGAR |
| SC 13G/A | 2021-02-11 | JANUS HENDERSON GROUP PLC | Phathom Pharmaceuticals, Inc. | 1,938,436 | 6.7% | EDGAR |
| SC 13D/A | 2020-12-23 | Frazier Life Sciences IX, L.P. | Phathom Pharmaceuticals, Inc. | 5,827,415 | 18.7% | EDGAR |
| SC 13D/A | 2020-06-17 | Frazier Life Sciences IX, L.P. | Phathom Pharmaceuticals, Inc. | 5,827,415 | 20.1% | EDGAR |
| SC 13G/A | 2020-02-14 | RA CAPITAL MANAGEMENT, L.P. | Phathom Pharmaceuticals, Inc. | 3,646,808 | 14.9% | EDGAR |
| SC 13G | 2020-02-14 | JANUS HENDERSON GROUP PLC | Phathom Pharmaceuticals, Inc. | 1,467,462 | 6.0% | EDGAR |
| SC 13G | 2020-02-13 | Invesco Ltd. | Phathom Pharmaceuticals, Inc. | 2,102,303 | 8.6% | EDGAR |
| SC 13G | 2020-02-10 | Medicxi Growth I LP | Phathom Pharmaceuticals, Inc. | 2,019,877 | 8.2% | EDGAR |
| SC 13G | 2020-02-10 | Yamada Tadataka | Phathom Pharmaceuticals, Inc. | 1,686,704 | 6.9% | EDGAR |